Metabolic Syndrome and Related Disorders
Impact Factor Trend (2018–2026)
Clarivate IF trend for Metabolic Syndrome and Related Disorders
SCImago Journal Rank citation prestige weighting
65 papers with at least that number of citations each
Aims & Scope
Metabolic Syndrome and Related Disorders is the only peer-reviewed journal focusing solely on the pathophysiology, recognition, and treatment of this major health condition. The Journal meets the imperative for comprehensive research, data, and commentary on metabolic disorder as a suspected precursor to a wide range of diseases, including type 2 diabetes, cardiovascular disease, stroke, cancer, polycystic ovary syndrome, gout, and asthma. Metabolic Syndrome and Related Disorders coverage includes: -Insulin resistance- Central obesity- Glucose intolerance- Dyslipidemia with elevated triglycerides- Low HDL-cholesterol- Microalbuminuria- Predominance of small dense LDL-cholesterol particles- Hypertension- Endothelial dysfunction- Oxidative stress- Inflammation- Related disorders of polycystic ovarian syndrome, fatty liver disease (NASH), and gout
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
MEDICINE, RESEARCH & EXPERIMENTAL
MEDICINE, RESEARCH & EXPERIMENTAL
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisMetabolic Syndrome and Related Disorders (abbr: METAB SYNDR RELAT D, ISSN: 1540-4196) is a peer-reviewed international scholarly journal in the field of MEDICINE, published by Mary Ann Liebert Inc. in United States since 2003. The periodical holds a Journal Impact Factor (JIF) of 1.60, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.548 (Q2), an H-index of 65.
The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 67 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,000 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics